Navigation Links
Stem cell research hopes to repair brain damage of Parkinson's disease
Date:11/11/2011

Australian scientists have developed a new technique using stem cells, in the hope to replace damaged cells in Parkinson's disease. The technique could be developed for application in other degenerative conditions.

Drs Clare Parish and Lachlan Thompson lead the research from the Florey Neuroscience Institutes and the University of Melbourne. They are members of the newly established Stem Cells Australia collaboration being launched at the University of Melbourne today.

Stem Cells Australia is a new $21m Australian Research Council Special Research Initiative bringing together Australia's leading stem cell scientists.

Led by internationally renowned stem cell expert Professor Martin Pera and administered by the University of Melbourne, the Initiative links Australia's leading experts in bioengineering, nanotechnology, stem cell biology, advanced molecular analysis and clinical research to solve some of the our biggest health challenges.

"Stem Cells Australia will not only play a major role in leading Australian research into stem cell science, it will help the Australian community to understand the impact of scientific breakthroughs in this fast-paced and fascinating field," he said.

Opening Stem Cells Australia on behalf of Innovation Minister Senator Kim Carr, ARC Chief Executive Officer Professor Margaret Sheil said the Initiative would make an important contribution to life-changing research.

"It will enable the delivery of stem cell research breakthroughs that will help ease suffering and save lives," Professor Sheil said.

Key areas of research include investigating the use of stem cells to rejuvenate and repair damaged and diseased cells in organs such as the heart, brain and blood that are affected in conditions such as heart disease, Parkinson's disease, stroke and Leukemia.

In regards to Parkinson's disease there is a progressive and permanent loss of a group of dopamine-producing brain cells that form an essential pathway in the brain circuitry controlling movement.

Drs Parish and Thompson's respective research groups have developed a novel technique using stem cells to replace the dopamine-producing brain cells.

The first step of the technique is led by Dr Parish's team which has expertise in generating the dopamine brain cells that are missing in Parkinson's disease.

"By following what we know about brain development we have been able to re-create an environment in the culture dish that allows us to generate specific cell types that may be therapeutic," she said.

"A limitation of the procedure, however, is that it is inefficient. This means that only around 30 per cent of the cells become dopamine brain cells while the others may remain as stem cells. This poses significant risks in a transplantation setting because the stem cells may continue to grow and form tumours," she said.

Dr Lachlan Thompson's team is working on an innovative approach using a state of the art cell-sorting technology to solve this problem.

"Overall we have identified some interesting findings that help us to isolate the dopamine brain cells and discard the stem cells prior to transplantation," he said.

"It's a strategy that we hope will bring us a step closer to clinical trials for a stem cell based treatment for Parkinson's. The broader significance is that this novel approach will likely be applicable to the development of stem cell-based treatments for other neurological conditions such as stroke, motor neuron disease and Huntington's disease," he said.

"There is still a lot of basic research to do to develop this technology to a point where it would be safe to proceed with trials in patients, however, there's no reason to think that it couldn't happen within the next 5-10 years with the proper funding."

Stem Cells Australia is a collaboration with eight Australian research partners: The University of Melbourne, Monash University, Walter and Eliza Hall Institute of Medical Research, The University of Queensland, University of NSW, Victor Chang Cardiac Research Institute, CSIRO and Florey Neuroscience Institutes. Former Governor of Victoria Professor David de Kretser is the Chair of the Governance Committee.

Professor Martin Pera said one of the major assets of the unique multidisciplinary approach of Stem Cells Australia is that it will foster and train the next generation of Australian stem cell scientists, cementing Australia's position in the field.

"This collaboration will not only support excellence in stem cell research to address diseases that are hardest to treat, but will also guide public debate about the important ethical, legal and societal issues associated with stem cell science," he said.


'/>"/>
Contact: Rebecca Scott
rebeccas@unimelb.edu.au
61-383-440-181
University of Melbourne
Source:Eurekalert

Related medicine news :

1. Requests for Alzheimers disease research grants up by 33 percent, as federal funding in doubt
2. New funding will help researchers learn how preschoolers move, battle early child obesity
3. Researcher finds elderly lose ability to distinguish between odors
4. NYU Langone expert calls for awareness, research of sudden death in patients with epilepsy
5. Office of Naval Research young investigators honored with Presidential Award
6. New Research Questions Wisdom of Cutting Down on Salt
7. Pitt researchers using mathematics to target Parkinsons disease symptoms
8. US grant exclusive for UK dementia researcher
9. New University of Houston research addresses problem drinking among college students
10. Moffitt Cancer Center researchers unravel biochemical factor important in tumor metastasis
11. Lose the fat and improve the gums, CWRU dental researchers find
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... ... April 28, 2017 , ... Beginning in 2017, Ridgecrest Herbals will be phasing ... the popular ClearLungs Extra Strength formula. To ensure that the effectiveness of Clear Lungs ... ways:, , Removal of the homeopathic element , ...
(Date:4/28/2017)... New York, NY (PRWEB) , ... April 28, ... ... Shiel Medical Laboratory to expanded distribution of the GlycoMark test throughout the Northeast ... indicates recent hyperglycemia in patients with diabetes. The GlycoMark test provides a clinically ...
(Date:4/28/2017)... Fairfax, VA (PRWEB) , ... April 28, 2017 , ... ... elected volunteer board members and officers for 2017-2018. The annual board election process has ... serving on a volunteer basis. , Thomas C. Dickerson, Ed.D., FACHE, succeeds Jim Hamilton, ...
(Date:4/28/2017)... ... ... The Texas Cord Blood Bank (TCBB), a program of nonprofit biomedical organization GenCure, ... at Renaissance in Edinburg for their outstanding efforts in collecting umbilical cord blood donations ... , “Women’s Hospital at Renaissance has been a collection partner for the TCBB since ...
(Date:4/28/2017)... ... April 28, 2017 , ... People are starting to accept that hearing aids ... doesn’t have the stigma it had when great-grandpa wore his hearing aids years ago,” ... a NALA North American Speaker Series (NASS) segment. “He probably wore an ...
Breaking Medicine News(10 mins):
(Date:4/25/2017)... April 25, 2017 Endo International plc (NASDAQ: ... 2017. Members of its senior management team will host a conference ... a.m. ET. The dial-in number to access the ... 509-7598, and the passcode is 6086379. Please dial in 10 minutes ... A replay of the call will be available from May ...
(Date:4/24/2017)... England , April 24, 2017 ... development, today announced the addition of a major ... ,Validated In-situ Plate Seeding,). The VIPS has been ... and 384 well microplates as part of the ... system offers a simple and more reliable solution ...
(Date:4/20/2017)... 20, 2017  Cogentix Medical, Inc. (NASDAQ: CGNT), ... the Urology, Uro/Gyn and Gynecology markets with innovative ... has joined the Company as Senior Vice President, ... position, Mr. Keswani will report directly to ... "Our organization is delighted that Ash has joined ...
Breaking Medicine Technology: